🇺🇸 Measles-Mumps-Rubella in United States

226 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pyrexia — 52 reports (23.01%)
  2. Contraindicated Product Administered — 30 reports (13.27%)
  3. Rash — 24 reports (10.62%)
  4. Measles — 23 reports (10.18%)
  5. Cough — 20 reports (8.85%)
  6. Decreased Appetite — 16 reports (7.08%)
  7. Drug Ineffective — 16 reports (7.08%)
  8. Depression — 15 reports (6.64%)
  9. Diarrhoea — 15 reports (6.64%)
  10. Drug Intolerance — 15 reports (6.64%)

Source database →

Other Immunology / Infectious Disease approved in United States

Frequently asked questions

Is Measles-Mumps-Rubella approved in United States?

Measles-Mumps-Rubella does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Measles-Mumps-Rubella in United States?

Hospital Clinic of Barcelona is the originator. The local marketing authorisation holder may differ — check the official source linked above.